Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Page Options
E-Mail This Search
Clinical Trial Questions?
Get Help:
1-800-4-CANCER
or
LiveHelp online chat
Quick Links
Help Using the NCI Clinical Trials Search Form
Educational Materials About Clinical Trials
About NCI's Cancer Clinical Trials Registry
Dictionary of Cancer Terms
NCI Drug Dictionary
View Content for:
Patients
Health Professionals
Display:
Title
Description with:
Locations
Eligibility
Full Trial Description
Custom
Results 1-10 of 10 for your search:
Drug:
epothilone ZK-219477
Find trials that include:
Any drugs shown
Trial Status:
Closed
Hide Search Criteria
Show Search Criteria
Help with Results
Select All on Page
Sort by:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Show
10
25
50
100
200
Results per Page
1.
Safety and Efficacy Study of a New Chemotherapy Agent to Treat Non-Small-Cell Lung Cancer
Phase:
Phase II
Type:
Treatment
Status:
Completed
Age:
18 and over
Sponsor:
Pharmaceutical / Industry
Protocol IDs:
91374
, EudraCT: 2005-000586-19, 307971, NCT00160069
2.
Efficacy and Safety Study of ZK219477 in Patients With Recurrent Ovarian Cancer
Phase:
Phase II
Type:
Treatment
Status:
Completed
Age:
18 and over
Sponsor:
Pharmaceutical / Industry
Protocol IDs:
91447
, EudraCT No: 2005-000635-15, 307970, NCT00246688
3.
Safety and Efficacy Study of a New Chemotherapy Agent to Treat Metastatic Breast Cancer
Phase:
Phase II
Type:
Treatment
Status:
Completed
Age:
18 and over
Sponsor:
Pharmaceutical / Industry
Protocol IDs:
91464
, EudraCT No: 2005-003216-30, 309544, NCT00288249
4.
Evaluation of a New Agent for Treatment of Advanced Stage Breast Cancer
Phase:
Phase II
Type:
Treatment
Status:
Completed
Age:
18 and over
Sponsor:
Pharmaceutical / Industry
Protocol IDs:
91466
, 307975, NCT00313248
5.
ZK-Epo Given With Carboplatin in Patients With Recurrent Ovarian Cancer
Phase:
Phase II
Type:
Treatment
Status:
Completed
Age:
18 and over
Sponsor:
Pharmaceutical / Industry
Protocol IDs:
91476
, 307979, NCT00325351
6.
ZK-Epo Given With Prednisone in Patients With Metastatic Androgen-Independent Prostate Cancer
Phase:
Phase II
Type:
Treatment
Status:
Closed
Age:
18 and over
Sponsor:
Pharmaceutical / Industry
Protocol IDs:
91500
, 307976, NCT00350051
7.
A Study of a New Chemotherapy Agent in Combination With Cisplatin to Treat Small Cell Lung Cancer
Phase:
Phase II
Type:
Treatment
Status:
Closed
Age:
18 and over
Sponsor:
Pharmaceutical / Industry
Protocol IDs:
91495
, EudraCT: 2006-000067-29, 310101, NCT00359359
8.
Phase II Study of Epothilone ZK-219477 in Patients With Recurrent Glioblastoma
Phase:
Phase II
Type:
Biomarker/Laboratory analysis, Treatment
Status:
Closed
Age:
18 and over
Sponsor:
Other, Pharmaceutical / Industry
Protocol IDs:
EORTC-26061
, EUDRACT-2006-001659-37, NCT00424060, SPRI-EORTC-26061
9.
Phase II Trial Of ZK-EPO (ZK 219477) In Metastatic Melanoma
Phase:
Phase II
Type:
Treatment
Status:
Closed
Age:
18 and over
Sponsor:
Other
Protocol IDs:
MCC-14965
, USFIRB#105272, ZK219477, 108.0701, NCT00598507
10.
Investigation Into How the Body Takes up the Test Drug and Distributes it Into Various Body Organs and Tissues, How it Processes the Drug and How it Ultimately Removes it
Phase:
Phase I
Type:
Biomarker/Laboratory analysis, Treatment
Status:
Completed
Age:
18 and over
Sponsor:
Pharmaceutical / Industry
Protocol IDs:
91490
, EUDRA-CT 2006-000188-26, 310301, NCT00432302
Select All on Page
Help with Results
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute